“…We followed an approach similar to that of Ahlers et al, who used a Cirrus Spectral domain OCT (software version, 2.0.1.3; Carl Zeiss Meditec, Inc., Dublin, CA). 5 ODRs were compared in patients with neovascular AMD, diabetic retinopathy (DR), RRD, CSR, RS, and pseudophakic cystoid macular edema (PCME). We speculated that analysis of the ODR and its variation in different ocular disease states would differentiate between pathologies in difficult diagnostic cases, and provide clues to the pathogenesis of retinal diseases.…”